Literature DB >> 25810489

How I treat priapism.

Uzoma A Anele1, Brian V Le1, Linda M S Resar2, Arthur L Burnett1.   

Abstract

Priapism is a disorder of persistent penile erection unrelated to sexual interest or desire. This pathologic condition, specifically the ischemic variant, is often associated with devastating complications, notably erectile dysfunction. Because priapism demonstrates high prevalence in patients with hematologic disorders, most commonly sickle cell disease (SCD), there is significant concern for its sequelae in this affected population. Thus, timely diagnosis and management are critical for the prevention or at least reduction of cavernosal tissue ischemia and potential damage consequent to each episode. Current guidelines and management strategies focus primarily on reactive treatments. However, an increasing understanding of the molecular pathophysiology of SCD-associated priapism has led to the identification of new potential therapeutic targets. Future agents are being developed and explored for use in the prevention of priapism.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2015        PMID: 25810489      PMCID: PMC4458797          DOI: 10.1182/blood-2014-09-551887

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  111 in total

Review 1.  Cyclic GMP phosphodiesterase-5: target of sildenafil.

Authors:  J D Corbin; S H Francis
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

2.  Hemolysis-associated priapism in sickle cell disease.

Authors:  Vikki G Nolan; Diego F Wyszynski; Lindsay A Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

3.  T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism.

Authors:  William O Brant; Maurice M Garcia; Anthony J Bella; Tom Chi; Tom F Lue
Journal:  J Urol       Date:  2009-02-23       Impact factor: 7.450

4.  Mechanisms of venous occlusion during canine penile erection: an anatomic demonstration.

Authors:  G R Fournier; K P Juenemann; T F Lue; E A Tanagho
Journal:  J Urol       Date:  1987-01       Impact factor: 7.450

Review 5.  A pathophysiology-based approach to the management of early priapism.

Authors:  Jason R Kovac; Siu K Mak; Maurice M Garcia; Tom F Lue
Journal:  Asian J Androl       Date:  2012-12-03       Impact factor: 3.285

6.  Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa.

Authors:  Annamaria Morelli; Sandra Filippi; Rosa Mancina; Michaela Luconi; Linda Vignozzi; Mirca Marini; Claudio Orlando; Gabriella Barbara Vannelli; Antonio Aversa; Alessandro Natali; Gianni Forti; Mauro Giorgi; Emmanuele A Jannini; Fabrizio Ledda; Mario Maggi
Journal:  Endocrinology       Date:  2004-02-05       Impact factor: 4.736

7.  The immediate insertion of a penile prosthesis for acute ischaemic priapism.

Authors:  David J Ralph; Giulio Garaffa; Asif Muneer; Alex Freeman; Rowland Rees; Andrew N Christopher; Sukbinder Minhas
Journal:  Eur Urol       Date:  2008-10-01       Impact factor: 20.096

8.  Follow-up of sickle cell disease patients with priapism treated by hydroxyurea.

Authors:  Sara T O Saad; Camila Lajolo; Simone Gilli; José Francisco C Marques Júnior; Carmen S Lima; Fernando F Costa; Valder R Arruda
Journal:  Am J Hematol       Date:  2004-09       Impact factor: 10.047

9.  Sickle cell disease status and outcomes of African-American men presenting with priapism.

Authors:  Nelson Bennett; John Mulhall
Journal:  J Sex Med       Date:  2008-02-25       Impact factor: 3.802

10.  Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress.

Authors:  Trinity J Bivalacqua; Biljana Musicki; Lewis L Hsu; Dan E Berkowitz; Hunter C Champion; Arthur L Burnett
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more
  12 in total

1.  Resolution of Acute Priapism in Two Children With Sickle Cell Disease Who Received Nitrous Oxide.

Authors:  Michael H Greenwald; Colleen K Gutman; Claudia R Morris
Journal:  Acad Emerg Med       Date:  2019-08-01       Impact factor: 3.451

Review 2.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

3.  Beneficial Effect of the Nitric Oxide Donor Compound 3-(1,3-Dioxoisoindolin-2-yl)Benzyl Nitrate on Dysregulated Phosphodiesterase 5, NADPH Oxidase, and Nitrosative Stress in the Sickle Cell Mouse Penis: Implication for Priapism Treatment.

Authors:  Fábio H Silva; Serkan Karakus; Biljana Musicki; Hotaka Matsui; Trinity J Bivalacqua; Jean L Dos Santos; Fernando F Costa; Arthur L Burnett
Journal:  J Pharmacol Exp Ther       Date:  2016-08-18       Impact factor: 4.030

4.  Steroids, drugs and stuttering priapism; the rock-and-roll lifestyle of a 24-year-old man.

Authors:  Lloyd Evans; Matt Larsen; Adam Cox; Rob Skyrme
Journal:  BMJ Case Rep       Date:  2016-01-28

Review 5.  Role of Penile Prosthesis in Priapism: A Review.

Authors:  Amit G Reddy; Laith M Alzweri; Andrew T Gabrielson; Gabriel Leinwand; Wayne J G Hellstrom
Journal:  World J Mens Health       Date:  2018-01       Impact factor: 5.400

Review 6.  Advances in the understanding of priapism.

Authors:  Matthew Hudnall; Amanda B Reed-Maldonado; Tom F Lue
Journal:  Transl Androl Urol       Date:  2017-04

7.  High-flow priapism treated with selective embolization of a helicine branch of the penile artery: A case report and selected review of the literature.

Authors:  Faizanahmed I Munshi; Young Suk Kwon; Douglas T Gibbens; Parvez Mahmood; Mukaram Gazi; Ephrem O Olweny
Journal:  Urol Ann       Date:  2019-11-07

8.  Essential Thrombocythemia Presenting with Recurrent Priapism: A Case Report and Review of Literature.

Authors:  Shailendra Prasad Verma; Nidhish Kumar; Mili Jain; Anil K Tripathi
Journal:  Am J Case Rep       Date:  2020-07-28

9.  TSPO ligand FGIN-1-27 controls priapism in sickle cell mice via endogenous testosterone production.

Authors:  Biljana Musicki; Serkan Karakus; Justin D La Favor; Haolin Chen; Fabio H Silva; Mikael Sturny; Barry R Zirkin; Arthur L Burnett
Journal:  J Cell Physiol       Date:  2020-09-24       Impact factor: 6.384

10.  Relationship between Response to PDE5 Inhibitors and Penile Duplex Doppler Ultrasound in Erectile Dysfunction.

Authors:  Ercan Ogreden; Ural Oğuz; Erhan Demirelli; Alptekin Tosun; Orhan Yalçın
Journal:  Med Sci (Basel)       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.